Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.

about

Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going?Pharmacotherapeutic Management of Pediatric Lymphoma.

P2860

Q42372842-E77D0361-4444-4767-9B14-BC288D3A7A4F Q48321203-351C872B-6480-44F5-A502-22D5D41D6E5E

P2860

Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.

Item

http://www.wikidata.org/entity/Q38691282

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Small Molecule Inhibitors in C ...... d B Cell Non-Hodgkin Lymphoma.

@en

type

Item

label

Small Molecule Inhibitors in C ...... d B Cell Non-Hodgkin Lymphoma.

@en

prefLabel

Small Molecule Inhibitors in C ...... d B Cell Non-Hodgkin Lymphoma.

@en

P1476

Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma

@en

P2093

Allison Rosenthal

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia

The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy

Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib

Ibrutinib in previously treated Waldenström's macroglobulinemia.

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer

An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

P2888

s11899-017-0383-0

P304

207-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11899-017-0383-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Allison C Rosenthal

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085052370

http://www.w3.org/2001/XMLSchema#string

P698

28439761

http://www.w3.org/2001/XMLSchema#string

P921

lymphoma

lymphocyte

Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.

about

P2860

P2860

Small Molecule Inhibitors in Chronic Lymphocytic Lymphoma and B Cell Non-Hodgkin Lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921